ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 149

$1.46M Total Retail Price of All Prescriptions

Rank: 1 out of 149

688 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 688 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

2% of this provider’s 688 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 18,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $96 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 1,208 949 1 5
LISINOPRIL 1,157 906 2 1
WARFARIN SODIUM 883 863 3 17
AMLODIPINE BESYLATE 855 723 4 2
OMEPRAZOLE 813 679 5 6
FUROSEMIDE 690 619 6 3
HYDROCHLOROTHIAZIDE 652 542 7 11
METOPROLOL TARTRATE 609 500 8 7
LEVOTHYROXINE SODIUM 547 484 9 19
METFORMIN HCL 413 310 10 22
CITALOPRAM HBR 357 315 11 26
ATORVASTATIN CALCIUM 340 244 12 15
IPRATROPIUM-ALBUTEROL 288 287 13 49
TRAZODONE HCL 235 234 14 42
SERTRALINE HCL 233 206 15 37
GLIPIZIDE 232 215 16 39
ALENDRONATE SODIUM 232 202 16 36
DIOVAN 219 180 18 13
INSULIN SYRINGE 217 134 19 46
POTASSIUM CHLORIDE 212 167 20 59
ALLOPURINOL 210 169 21 16
DONEPEZIL HCL 202 202 22 48
RENVELA 192 67 23 8
ATENOLOL 179 124 24 20
QUINAPRIL HCL 179 150 24 66
GABAPENTIN 177 116 26 32
NOVOLOG 173 157 27 67
TAMSULOSIN HCL 164 163 28 29
PANTOPRAZOLE SODIUM 164 124 28 45
LANTUS 163 132 30 57
MIRTAZAPINE 160 160 31 54
NYSTOP 159 158 32 70
GLYBURIDE 157 157 R 33 47
ISOSORBIDE MONONITRATE ER 154 135 34 43
COLCRYS 153 124 35 72
NOVOLIN 70-30 150 149 36 73
PEN NEEDLE 145 100 37 75
METOPROLOL SUCCINATE 143 89 38 14
PREDNISONE 139 111 39 9
NOVOLOG MIX 70-30 138 105 40 78
NAMENDA 134 134 41 62
DIVALPROEX SODIUM 131 131 42 81
RISPERIDONE 127 127 43 85
DIGOXIN 125 97 44 56
FENOFIBRATE 124 89 45 86
FINASTERIDE 123 123 46 51
JANUVIA 123 106 46 88
SENSIPAR 118 21 48 10
ADVAIR DISKUS 115 104 49 91
PAROXETINE HCL 113 99 50 58
HUMALOG MIX 75-25 112 91 51 95
HYDRALAZINE HCL 107 69 52 21
LOSARTAN POTASSIUM 106 67 53 12
CLOPIDOGREL 104 78 54 99
HUMULIN N 103 98 55 69
LOVASTATIN 102 82 56 60
PRAVASTATIN SODIUM 101 84 57 33
CARVEDILOL 101 72 57 23
DOXAZOSIN MESYLATE 98 68 59 24
QUETIAPINE FUMARATE 94 94 60 100
DILTIAZEM 24HR CD 93 83 61 101
RANITIDINE HCL 93 86 61 50
CYMBALTA 92 76 63 74
KLOR-CON M20 90 90 64 68
LIPITOR 84 59 65 52
ENALAPRIL MALEATE 83 61 66 79
LEVETIRACETAM 82 63 67 104
ZOLPIDEM TARTRATE 81 42 68 34
PLAVIX 79 58 69 106
NYSTATIN 77 68 70 109
NITROGLYCERIN PATCH 76 76 71 111
VERAPAMIL ER 76 53 71 81
LIDODERM 75 70 73 112
OXYBUTYNIN CHLORIDE ER 75 75 73 112
FLUTICASONE PROPIONATE 72 64 75 114
ACTONEL 71 71 76 116
SEROQUEL 70 70 77 118
CARBIDOPA-LEVODOPA 69 44 78 119
CRESTOR 68 44 79 44
TRAMADOL HCL 68 68 79 39
NEXIUM 68 39 79 121
TRICOR 68 40 79 121
SPIRIVA 66 55 83 84
METFORMIN HCL ER 64 46 84 125
NOVOLOG MIX 70-30 FLEXPEN 63 24 85 126
HUMALOG 63 34 85 126
KLOR-CON M10 61 59 87 128
LEVOFLOXACIN 60 57 88 129
AZITHROMYCIN 60 38 88 76
LEVEMIR FLEXPEN 56 19 90 133
DILTIAZEM HCL 54 54 91 135
DIOVAN HCT 54 49 91 98
FLOVENT HFA 54 43 91 135
ESCITALOPRAM OXALATE 54 47 91 135
DOXEPIN HCL 53 53 95 138
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 46 95 27
NYSTATIN-TRIAMCINOLONE 52 52 97 141
ZETIA 51 25 98 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.